Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
I'm sure that will be a wise decision Open the only thing I would say is that previous highs were based on undelivered expectations hence the subsequent price falls. When the share price next passes 15p on it's rise to the 20's it will be due to delivering on the profit numbers. If profits continue to increase the sp will follow so a different situation to previous highs. With the payment of dividends also on the table the decision of selling for me is slightly more complicated but anywhere in the 20's will be difficult to resist. I can imagine you ranting on this BB for years about missing out on 57p!
It is and incredibly frustrating but all cpx can do is continue its progress towards profitability with increased sales and profit margins as has been reported. The market is disorientated at the moment, I'm heavily invested here and will remain so content that the company is making good progress and is in no way an AIM dud. It's been too many years and sometimes demoralising but when ebitda profitability is achieved the market must correct this imbalance at some point.
This was posted some time ago can't remember who by but the information especially the paragraph below I think is very relevant to whether it is working and carries much more value/credibility to the point about whether phase 1 is just purely about safety. I just can't see how the trial would have continued for so long at such high doses if there was absolutely no benefit.
https://www.bmj.com/careers/article/professor-james-spicer-professor-of-experimental-cancer-medicine-king-s-college-london
We need to stop it, and that's explicitly an intention of early phase, Phase I trials. One major contribution we can make is to take a drug which is actually not doing what it should, to discontinue its development as soon as possible. Before too many patients are exposed to an ineffective drug, and before too much money is wasted trying to develop it.
Very true Wiggly and whilst some may doubt the credibility of what Avacta's communicaes there is no doubt the safety committee would not allow a terminally ill patient to be injected with poison at such high doses for this length of time just to see how much of an ineffective concoction they can pump in. Totally unethical and has already been stated in an interview by a senior member of the committee that one of their most important functions is to stop these trials as soon as possible if there is little chance of success. For this reason I am sure it is cleaving and to a level that is potentially effective maybe not as good as preclinical but nonetheless to a degree that they see merit in the trials continuation. This independent validation for me is the most important sign of success and can't be muddled with the past lack of success in projects that Avacta were directly heavily promoting.
I take your point Mer I hadn't assumed whoever asked that question was assuming dividends could be paid to reward shareholders as of now. From my perspective I wasn't thinking they would pay a dividend when profitability is achieved but instead would be investing profits for growth. Hopefully we'll get a double bonus with a increase in sp and a dividend payout.
The last answer to the agm questions suggest a payment of dividends when profitability is achieved. That will certainly help the sp and would be a strong reason to keep hold of any large shareholding. Might have to rethink my strategy of off loading a few at 20p.
That's one of the most upbeat statements we've ever had and to think 60m pipeline from what is basically the relatively low value prizmatic products with 4 x production capacity available at 7 Hills. A few orders from the other product range as hinted with the Ioxus order will have a big impact on the numbers assuming large cap modules and truckstart are typically more expensive products although understandably won't sell in the volumes of prizmatic cells. No mention of Maxwell which still rumbles on but in no way should be holding back the sp or progress perhaps not a bad thing to take focus away from what seems to be a unnecessary distraction to the sp.
It looks very clear to me in that they will only allocate unused entitlements and that paragraph relates to how they will distribute unused entitlements if at all based on several factors. I've seen instances in the past where for example any requests over a substantial request such as say 5000 were declined in full so no excess shares allocated to those requests. It may be that they scale back all requests regardless of amount requested to say 500. Might be prudent to request a sensible amount around 1000 to be safe of getting some but we'll find out soon.
For long term suffering shareholders it's best to reset your clock and view the past 6 or so years as the accumulation phase that has allowed you to obtain a substantial stake in a well researched company. From the reset date the company is now increasing sales, profit margins and has a greater variety of products in its move towards profitability. The turbulent times over the last couple of years is causing a drop in the sp yet the company is progressing. It won't be as big as Amazon but the market will correct itself just like it always does and cpx have never before been in this position so when it does the sp potential will be in completely new territory that may well see new all time highs. On that basis I'll be waiting for the 20's before selling some of what for me is a substantial holding of nearly 2m shares. Good luck all lth's hopefully our patience is soon rewarded.
Funny you should say that I mistakenly totalled up the value of my investments early 2021 and started to dream following the unexpected rise in pretty much all my shares. Didn't see it turning into the nightmare it currently is but Halloween will soon be over maybe Santa will bring some xmas cheer!
My view is that this is an amazing technological development but has been an investors nightmare over the last 6 or so years due to the delays and extreme challenges in continuing to finance its development.
Nonetheless it is now at a pivotal stage and if demand is as predicted the potential is substantial and whilst there is still work to do to complete the accreditation process the risks compared to 12 months ago are greatly reduced. Can't explain the sp reaction over the last few days following the news of achieving 230MeV but a few new orders and production plans being confirmed could see a significant upturn.
It could be worse look at ITM today and the other green energy companies over the last 6 months. Cpx has been dragged down with the sector but unlike these other companies it is uniquely becoming a profitable business and at sometime will differentiate itself from the rest and be valued correctly inline with its financial performance.
Apologies if it's been covered but what is the relevance of Newcastle being mentioned. I'm assuming this arrangement is for samples from any site conducting trials.
Anyhow looks like great news confirming what AS has always suggested regarding having biopsy data.
Someone on advfn thinks sp drop might be as a result of a forthcoming placing. This could be correct and would be disappointing if it is at such a low price considering the recent news. If funds are raised and are substantial and intended for the manufacture of systems including for Harley St. then I would view it as a positive but we will see.
Unless the investor day is planned to announce a raft of bad news and OAM haven't a clue what they are doing with their additional £6m investment this sp after the significant 230MeV announcement is completely bewildering. I'm not selling and will wait for the accreditation process to be completed and hopefully news of orders over the coming months.
To be fair that truckstart product is a rebadged Ioxus product that came out of the blue. I've said it before all the previous MoU's, partnerships etc have pretty much come to nothing so JH's comments are valid. However the murata deal has changed everything and puts cpx in control of customer deals for prizmatic products within the rapidly growing IoT market. The Ioxus deal allows cpx to enter new markets with products that JH is referring to and finally winning the Maxwell court case completes a very strong picture that positions cpx very well in the green energy market.
I'm sure an amicable arrangement is in place for the rent. I'd like to hear that they will commence manufacturing of the Harley St. machine followed by its installation as soon as possible without waiting for completion of the accreditation process that also includes patient treatment at Daresbury. Otherwise Harley St. won't be operational until well into 2024. News of other commercial deals would also be welcome with such an innovative technological development you'd hope they'd be lining up outside Daresbury.